333 related articles for article (PubMed ID: 28657358)
1. Adeno-Associated Virus (AAV) gene therapy for cystic fibrosis: current barriers and recent developments.
Guggino WB; Cebotaru L
Expert Opin Biol Ther; 2017 Oct; 17(10):1265-1273. PubMed ID: 28657358
[TBL] [Abstract][Full Text] [Related]
2. Gene Therapy for Cystic Fibrosis Paved the Way for the Use of Adeno-Associated Virus in Gene Therapy.
Guggino WB; Cebotaru L
Hum Gene Ther; 2020 May; 31(9-10):538-541. PubMed ID: 32283956
[TBL] [Abstract][Full Text] [Related]
3. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.
Wagner JA; Messner AH; Moran ML; Daifuku R; Kouyama K; Desch JK; Manley S; Norbash AM; Conrad CK; Friborg S; Reynolds T; Guggino WB; Moss RB; Carter BJ; Wine JJ; Flotte TR; Gardner P
Laryngoscope; 1999 Feb; 109(2 Pt 1):266-74. PubMed ID: 10890777
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of a recombinant adeno-associated virus 5-pseudotyped cystic fibrosis transmembrane conductance regulator vector.
Sirninger J; Muller C; Braag S; Tang Q; Yue H; Detrisac C; Ferkol T; Guggino WB; Flotte TR
Hum Gene Ther; 2004 Sep; 15(9):832-41. PubMed ID: 15353038
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy in cystic fibrosis.
Flotte TR; Laube BL
Chest; 2001 Sep; 120(3 Suppl):124S-131S. PubMed ID: 11555567
[TBL] [Abstract][Full Text] [Related]
6. Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells.
Liu X; Luo M; Zhang LN; Yan Z; Zak R; Ding W; Mansfield SG; Mitchell LG; Engelhardt JF
Hum Gene Ther; 2005 Sep; 16(9):1116-23. PubMed ID: 16149910
[TBL] [Abstract][Full Text] [Related]
7. A Preclinical Study in Rhesus Macaques for Cystic Fibrosis to Assess Gene Transfer and Transduction by AAV1 and AAV5 with a Dual-Luciferase Reporter System.
Guggino WB; Benson J; Seagrave J; Yan Z; Engelhardt J; Gao G; Conlon TJ; Cebotaru L
Hum Gene Ther Clin Dev; 2017 Sep; 28(3):145-156. PubMed ID: 28726496
[TBL] [Abstract][Full Text] [Related]
8. Novel Lung Tropic Adeno-Associated Virus Capsids for Therapeutic Gene Delivery.
Carneiro A; Lee H; Lin L; van Haasteren J; Schaffer DV
Hum Gene Ther; 2020 Sep; 31(17-18):996-1009. PubMed ID: 32799685
[TBL] [Abstract][Full Text] [Related]
9. Genetic modification of adeno-associated viral vector type 2 capsid enhances gene transfer efficiency in polarized human airway epithelial cells.
White AF; Mazur M; Sorscher EJ; Zinn KR; Ponnazhagan S
Hum Gene Ther; 2008 Dec; 19(12):1407-14. PubMed ID: 18778196
[TBL] [Abstract][Full Text] [Related]
10. A Novel AAV-mediated Gene Delivery System Corrects CFTR Function in Pigs.
Cooney AL; Thornell IM; Singh BK; Shah VS; Stoltz DA; McCray PB; Zabner J; Sinn PL
Am J Respir Cell Mol Biol; 2019 Dec; 61(6):747-754. PubMed ID: 31184507
[TBL] [Abstract][Full Text] [Related]
11. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.
Flotte TR; Afione SA; Conrad C; McGrath SA; Solow R; Oka H; Zeitlin PL; Guggino WB; Carter BJ
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10613-7. PubMed ID: 7504271
[TBL] [Abstract][Full Text] [Related]
12. Efficient CFTR expression from AAV vectors packaged with promoters--the second generation.
Wang D; Fischer H; Zhang L; Fan P; Ding RX; Dong J
Gene Ther; 1999 Apr; 6(4):667-75. PubMed ID: 10476227
[TBL] [Abstract][Full Text] [Related]
13. Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy.
Flotte TR
Curr Opin Mol Ther; 2001 Oct; 3(5):497-502. PubMed ID: 11699895
[TBL] [Abstract][Full Text] [Related]
14. Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung.
Conrad CK; Allen SS; Afione SA; Reynolds TC; Beck SE; Fee-Maki M; Barrazza-Ortiz X; Adams R; Askin FB; Carter BJ; Guggino WB; Flotte TR
Gene Ther; 1996 Aug; 3(8):658-68. PubMed ID: 8854091
[TBL] [Abstract][Full Text] [Related]
15. A shortened adeno-associated virus expression cassette for CFTR gene transfer to cystic fibrosis airway epithelia.
Ostedgaard LS; Rokhlina T; Karp PH; Lashmit P; Afione S; Schmidt M; Zabner J; Stinski MF; Chiorini JA; Welsh MJ
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2952-7. PubMed ID: 15703296
[TBL] [Abstract][Full Text] [Related]
16. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter.
Flotte TR; Afione SA; Solow R; Drumm ML; Markakis D; Guggino WB; Zeitlin PL; Carter BJ
J Biol Chem; 1993 Feb; 268(5):3781-90. PubMed ID: 7679117
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors.
Halbert CL; Miller AD; McNamara S; Emerson J; Gibson RL; Ramsey B; Aitken ML
Hum Gene Ther; 2006 Apr; 17(4):440-7. PubMed ID: 16610931
[TBL] [Abstract][Full Text] [Related]
18. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study.
Flotte TR; Zeitlin PL; Reynolds TC; Heald AE; Pedersen P; Beck S; Conrad CK; Brass-Ernst L; Humphries M; Sullivan K; Wetzel R; Taylor G; Carter BJ; Guggino WB
Hum Gene Ther; 2003 Jul; 14(11):1079-88. PubMed ID: 12885347
[TBL] [Abstract][Full Text] [Related]
19. A sensitive, real-time, RNA-specific PCR method for the detection of recombinant AAV-CFTR vector expression.
Gerard CJ; Dell'Aringa J; Hale KA; Klump WM
Gene Ther; 2003 Sep; 10(20):1744-53. PubMed ID: 12939641
[TBL] [Abstract][Full Text] [Related]
20. Technology evaluation: AAV-CFTR vector, targeted genetics.
Tebbutt SJ
Curr Opin Mol Ther; 1999 Aug; 1(4):524-9. PubMed ID: 11713770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
